CGMX
DEAD

Serial Number

79426034

Owner

GlucoRx Ltd

Filing Date

Feb 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CGMX Trademark

Serial Number: 79426034

CGMX is a trademark filed by GlucoRx Ltd on February 26, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

GlucoRx Ltd (4 trademarks)

Unit 1c Henley Business Park,

Entity Type: 99

Trademark Details

Filing Date

February 26, 2025

Registration Date

Not Registered

Goods & Services

Medical devices for medical and surgical use; medical, weight management, lifestyle and wellness devices for human and veterinary purposes; sensors that are implanted or inserted into the body used to continuously monitor the concentration of physiological analytes in the body; non-invasive sensors that are used to continuously monitor the concentration of physiological analytes in the body and associated accessories, namely, receivers, sensor housings and sensor insertion devices; medical apparatus and instruments; analytes measuring meters; pumps for medical purposes; insulin pens; patient monitoring instruments, sensors and alarms (measurement apparatus) for medical purposes; diagnostic, examination and monitoring equipment; diagnostic apparatus for medical use; monitors and devices for monitoring electrocardiography, carbondioxide levels, oxygen saturation, exercise and activity monitor, cardiac activity, and other body functions; pulse meters, heart rate monitoring apparatus and body composition monitors

Online advertising on a computer network; advertising; commercial administration of the licensing of the goods and services of others; providing business information via a website; sales promotion for others; provision of an online marketplace for buyers and sellers of goods and services; import-export agency services; updating and maintenance of data in computer databases; retail and wholesale services for pharmaceuticals; business auditing

Software for use by one or more individuals to acquire, receive, store, process, analyse, access, present, repo and or transmit medical and physiological data; software applications for mobile devices for monitoring and managing patient medical information; apparatus and instruments for receiving and storing sound and data in digital form; health monitoring software; artificial intelligence software for healthcare; machine learning software for healthcare

Test strips for measuring blood analytes levels; diagnostic preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for treating diabetes; antidiabetic pharmaceuticals; antidiabetic preparations; dietetic foods adapted for medical purposes; veterinary diagnostic reagents; wellbeing, athletes, lifestyle, weight management and metabolic syndrome diagnostics reagents; massage creams for medical purposes; insulin pens sold filled with insulin; analytes test strips

Filing History

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 19, 2026 CORN
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 30, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 30, 2026 ABN2
REFUSAL PROCESSED BY IB
Sep 27, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 10, 2025 RFRR
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 8, 2025 CRCV
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 1, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 31, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 26, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 26, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 26, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 19, 2025 REPR